Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 32.86%355.4M | 28.85%124.6M | 300.41%193M | 139.52%11.5M | -82.66%26.3M | 110.63%267.5M | -37.49%96.7M | -44.15%48.2M | 74.65%-29.1M | 18,862.50%151.7M |
Net income from continuing operations | -57.34%369.8M | -84.24%130.6M | 270.00%62.9M | 652.38%150.8M | -47.53%25.5M | 376.79%866.8M | 2,563.99%828.5M | -78.12%17M | -124.20%-27.3M | 222.11%48.6M |
Operating gains losses | 164.71%8.8M | -33.33%-13.2M | 1,100.00%24M | -80.00%400K | 27.27%-2.4M | 92.53%-13.6M | 39.63%-9.9M | 65.71%-2.4M | 101.35%2M | 69.44%-3.3M |
Depreciation and amortization | 20.77%122.1M | 23.27%33.9M | 22.87%31.7M | 21.22%29.7M | 15.02%26.8M | 10.86%101.1M | 55.37%27.5M | 4.45%25.8M | -0.81%24.5M | -3.32%23.3M |
Deferred tax | 100.74%5.8M | 98.29%-13.5M | 179.17%3.8M | 440.00%13.5M | -56.52%2M | -10,054.43%-786.4M | -98,687.50%-788.7M | -1,300.00%-4.8M | -65.75%2.5M | 866.67%4.6M |
Other non cash items | 9.90%-44.6M | -464.29%-15.3M | 202.38%25.8M | -8,460.00%-42.8M | 56.07%-12.3M | -189.47%-49.5M | -45.45%4.2M | -240.00%-25.2M | 98.56%-500K | -250.00%-28M |
Change In working capital | -210.18%-134.2M | -111.72%-3.2M | 21.94%37.8M | -295.44%-147.5M | -121.13%-21.3M | 1,945.45%121.8M | -74.70%27.3M | 196.57%31M | 67.54%-37.3M | 210.15%100.8M |
-Change in receivables | -244.54%-64.9M | ---- | ---- | ---- | ---- | 750.72%44.9M | ---- | ---- | ---- | ---- |
-Change in other current assets | 479.66%22.4M | ---- | ---- | ---- | ---- | -1,280.00%-5.9M | ---- | ---- | ---- | ---- |
-Change in other current liabilities | -210.75%-91.7M | ---- | ---- | ---- | ---- | 41,500.00%82.8M | ---- | ---- | ---- | ---- |
-Change in other working capital | ---- | ---- | 21.94%37.8M | ---- | ---- | ---- | ---- | 196.57%31M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 32.86%355.4M | 28.85%124.6M | 300.41%193M | 139.52%11.5M | -82.66%26.3M | 110.63%267.5M | -37.49%96.7M | -44.15%48.2M | 74.65%-29.1M | 18,862.50%151.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 32.07%-452.3M | 76.38%-109.1M | 22.61%-81.8M | -162.14%-110.1M | -169.22%-151.3M | -3,886.83%-665.8M | -372.35%-461.9M | 54.67%-105.7M | -149.94%-42M | -51.08%-56.2M |
Net PPE purchase and sale | 34.62%-455.1M | 75.87%-111.7M | 22.59%-81.9M | -55.21%-110.2M | -168.74%-151.3M | -236.28%-696.1M | -759.00%-463M | -97.76%-105.8M | -16.20%-71M | -46.23%-56.3M |
Net investment purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | -90.76%2.8M | 136.36%2.6M | 0.00%100K | ---- | ---- | -84.08%30.3M | -68.57%1.1M | -99.75%100K | -80.03%29M | -92.31%100K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 32.07%-452.3M | 76.38%-109.1M | 22.61%-81.8M | -162.14%-110.1M | -169.22%-151.3M | -3,886.83%-665.8M | -372.35%-461.9M | 54.67%-105.7M | -149.94%-42M | -51.08%-56.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -155.45%-158.3M | 51.77%-27.2M | -141.78%-129.3M | -100.62%-200K | -1.6M | 4,560.94%285.5M | -56.4M | 5,091.94%309.5M | 32.4M | 0 |
Net issuance payments of debt | --0 | --0 | --0 | ---- | ---- | --531.2M | --0 | --403M | ---- | ---- |
Net common stock issuance | 36.35%-126.4M | 51.17%-25M | -20.48%-100M | ---- | ---- | ---198.6M | ---51.2M | ---83M | ---- | ---- |
Net other financing activities | 32.27%-31.9M | 57.69%-2.2M | -179.05%-29.3M | --1.2M | ---1.6M | -635.94%-47.1M | ---5.2M | -69.35%-10.5M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -155.45%-158.3M | 51.77%-27.2M | -141.78%-129.3M | -100.62%-200K | ---1.6M | 4,560.94%285.5M | ---56.4M | 5,091.94%309.5M | --32.4M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -15.07%635.7M | -62.91%392.2M | -49.05%410.3M | -39.68%509.1M | -15.07%635.7M | 16.12%748.5M | 149.25%1.06B | 39.49%805.3M | 38.77%844M | 16.12%748.5M |
Current changes in cash | -126.24%-255.2M | 97.22%-11.7M | -107.18%-18.1M | -155.30%-98.8M | -232.57%-126.6M | -208.57%-112.8M | -230.00%-421.6M | 264.60%252M | -25.24%-38.7M | 362.36%95.5M |
End cash Position | -40.14%380.5M | -40.14%380.5M | -62.91%392.2M | -49.05%410.3M | -39.68%509.1M | -15.07%635.7M | -15.07%635.7M | 149.25%1.06B | 39.49%805.3M | 38.77%844M |
Free cash flow | 76.74%-99.7M | 103.52%12.9M | 292.88%111.1M | 1.40%-98.7M | -231.03%-125M | -435.75%-428.6M | -463.39%-366.3M | -275.61%-57.6M | 43.09%-100.1M | 353.05%95.4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |